1/46
Vocabulary flashcards covering key terms and concepts from the Drug Interactions lecture notes.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
Drug interaction
Pharmacological or clinical response to a drug combination that differs from the expected effects of the two drugs given alone; includes antagonism and synergism.
Antagonism
A drug interaction where the combined effect is less than the sum of the effects of each drug given alone.
Synergism
A drug interaction where the combined effect is greater than the sum of the individual effects.
Pharmacokinetic interaction
An interaction in which one drug changes the absorption, distribution, metabolism, or excretion of another, altering its plasma concentration.
Pharmacodynamic interaction
An interaction where one drug changes a patient’s response to another drug without changing the kinetics of the second drug.
Pharmaceutical interaction
Physical or chemical incompatibilities between drugs (e.g., IV admixtures).
Drug-food interaction
Interactions between drugs and foods or other non-drug substances (enteral products, nutrients, alcohol, tobacco) affecting absorption or effect.
Enteral products
Foods or nutrients administered through the GI tract that can interact with drugs.
Narrow therapeutic range
Drugs with a small margin between therapeutic and toxic doses (e.g., digoxin, theophylline).
Steep dose–response curve
Small changes in dose produce large changes in effect (e.g., phenytoin, aminoglycosides).
Object drugs
Drugs with a narrow therapeutic range, a steep dose–response, hepatic metabolism, and typically used chronically.
Complexation
Mechanism where two drugs form a chemical complex, reducing absorption (e.g., with cholestyramine or metal ions in antacids).
Bile acid resins
Cholestyramine and colestipol; form complexes that lower absorption of other drugs.
Metal ions in interfering products
Divalent/trivalent ions (Mg2+, Ca2+, Zn2+, Fe2+/Fe3+, Al3+) in antacids/multivitamins that chelate drugs and reduce absorption.
Changes in pH (absorption)
Drug-induced pH changes that alter dissolution and absorption; examples include H2 blockers, PPIs, and antacids.
H2 receptor blockers
Cimetidine and ranitidine; raise gastric pH and can reduce absorption of acid-dependent drugs.
Proton pump inhibitors
Omeprazole and lansoprazole; raise gastric pH, affecting dissolution of some drugs.
Antacids
Alkaline preparations that raise gastric pH and can affect dissolution of certain drugs.
Drugs needing acid pH for dissolution
Drugs that require acidic conditions to dissolve (e.g., ketoconazole, itraconazole, iron supplements).
Changes in GI motility
Drugs that slow (e.g., opioids, anticholinergics; antihistamines, TCAs, phenothiazines) or speed (e.g., laxatives, metoclopramide, erythromycin) GI transit, altering absorption.
Opioids (GI effect)
Drugs that slow GI motility, potentially delaying absorption.
Erythromycin (GI effect)
A macrolide that can speed GI motility, altering absorption of concomitant drugs.
Absorption (drug interactions)
Pharmacokinetic interactions that change the extent or rate of drug absorption.
Cytochrome P‑450 (CYP450)
A family of enzymes responsible for drug metabolism; major isoforms include CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4/3A3.
CYP2D6 polymorphism
Genetic variation leading to poor, intermediate, extensive, or ultrarapid metabolism; ~25% of clinically used drugs metabolized by CYP2D6.
Poor metabolizer
Individual with very low CYP2D6 activity, leading to slower drug metabolism.
Ultrarapid metabolizer
Individual with high CYP2D6 activity, leading to faster drug metabolism.
Factors affecting metabolism: age (very young)
In neonates, glucuronidation is immature (Gray Baby syndrome) due to deficient Phase-2 enzymes.
Factors affecting metabolism: elderly
Reduced metabolism and excretion; more drugs used concurrently; dosing escalation often needed.
Disease state effect on metabolism
Liver diseases (hepatitis, hepatic cancer) reduce drug clearance and increase overdose risk.
Enzyme induction
Drugs that increase hepatic metabolic enzyme levels, increasing metabolism of substrates; onset days to weeks; offset weeks after stopping.
Enzyme inducers
Examples include barbiturates, phenytoin, primidone, carbamazepine, rifampin, ritonavir, plus cigarette smoking, chronic alcohol use, charbroiled meat.
Time course of induction
Induction onset ~5 days; maximum ~2 weeks; offset 3+ weeks after stopping.
Enzyme inhibition
Drugs that decrease CYP enzyme activity, increasing substrate concentrations and effects.
Time course of inhibition
Inhibition often rapid; maximal within 24 hours; offset usually within 24 hours after discontinuation.
Important enzyme inhibitors
Amiodarone, cimetidine, ciprofloxacin, clarithromycin, diltiazem, fluoxetine, ketoconazole, lovastatin, metoclopramide, omeprazole, SMX/TMP, sertraline, verapamil, ticlopidine.
Pharmacodynamic interaction
Effect of one drug on the concentration–effect relationship of another drug without pharmacokinetic changes.
Antagonistic pharmacodynamic interactions
One drug reduces or blocks the effect of another (example: cholinergic antagonist diminishing cholinergic therapy).
Synergistic/additive pharmacodynamic effects
Combined effects that are greater (or more adverse) than either drug alone.
Additive CNS depressant effects
Combined sedation from alcohol, analgesics, antihistamines, barbiturates, benzodiazepines, beta-blockers, anticonvulsants, sedatives, phenothiazines, TCAs, anesthetics, muscle relaxants.
Additive anticholinergic effects
Cumulative antimuscarinic effects from multiple drugs (e.g., haloperidol, amitriptyline, benztropine, scopolamine, dicyclomine, diphenhydramine, benzodiazepines).
Antagonistic example
Cholinergic and anticholinergic drugs (e.g., donepezil with tolterodine) may worsen urinary incontinence through opposing actions.
Herbs and drug interactions: Ginseng
Ginseng can increase INR when taken with warfarin.
Herbs and drug interactions: Garlic
Garlic has antiplatelet effects; interactions with aspirin, warfarin, ticlopidine, clopidogrel, dipyridamole.
Herbs and drug interactions: Ginkgo biloba
Ginkgo has antiplatelet effects; interactions with aspirin, warfarin, ticlopidine, clopidogrel, dipyridamole.
Herbs and drug interactions: Ginger
Ginger can potentiate anticoagulants (e.g., warfarin) via thromboxane pathway effects.
Herbs and drug interactions: St. John’s Wort
Herbal that can induce CYP enzymes and affect MAOI/SSRI interactions; can reduce levels of many drugs.